Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP

Overview of attention for article published in Drug Design, Development and Therapy, May 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

patent: 3 patents

video: 1 YouTube creator

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 56 Mendeley

Summary Patents YouTube Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

COMPOUNDS

Application WO-2024175930-A1

World Intellectual Property Organisation (WIPO)

NOVEL TRIPLE ACTIVATOR HAVING ACTIVITY ON ALL OF GLP-1, GIP, AND GLUCAGON RECEPTORS, AND…

Application WO-2024136573-A1

World Intellectual Property Organisation (WIPO)

NOVEL GLP-1 RECEPTOR ANTAGONIST, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR…

Application WO-2024080824-A1

World Intellectual Property Organisation (WIPO)